Breaking News Instant updates and real-time market news.

CKPT

Checkpoint Therapeutics

$3.31 /

-0.045 (-1.34%)

16:07
01/19/21
01/19
16:07
01/19/21
16:07

Checkpoint Therapeutics initiated with an Overweight at Cantor Fitzgerald

Cantor Fitzgerald analyst Jennifer Kim initiated coverage of Checkpoint Therapeutics with an Overweight rating and $16 price target.

  • 18

    Sep

CKPT Checkpoint Therapeutics
$3.31 /

-0.045 (-1.34%)

09/29/20 H.C. Wainwright
Checkpoint Therapeutics price target raised to $17 from $15 at H.C. Wainwright
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
04/13/20 B. Riley Securities
AstraZeneca study halt has positive read-through to Fortress, says B. Riley FBR

TODAY'S FREE FLY STORIES

Recommendations
Toll Brothers price target raised to $62 from $51 at Citi » 06:23
02/25/21
02/25
06:23
02/25/21
06:23
TOL

Toll Brothers

$55.98 /

+1.74 (+3.21%)

Citi analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TOL Toll Brothers
$55.98 /

+1.74 (+3.21%)

TOL Toll Brothers
$55.98 /

+1.74 (+3.21%)

01/28/21 Wedbush
Toll Brothers downgraded to Neutral on valuation at Wedbush
01/28/21 Wedbush
Toll Brothers downgraded to Neutral from Outperform at Wedbush
12/08/20 UBS
NVR, Masco, LGI Homes, DR Horton, Fortune Brands top UBS picks in Building space
12/08/20 UBS
Toll Brothers initiated with a Buy at UBS
TOL Toll Brothers
$55.98 /

+1.74 (+3.21%)

TOL Toll Brothers
$55.98 /

+1.74 (+3.21%)

TOL Toll Brothers
$55.98 /

+1.74 (+3.21%)

TOL Toll Brothers
$55.98 /

+1.74 (+3.21%)

Earnings
Acushnet Holdings reports Q4 EPS 29c, consensus 13c » 06:23
02/25/21
02/25
06:23
02/25/21
06:23
GOLF

Acushnet Holdings

$44.01 /

-0.605 (-1.36%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOLF Acushnet Holdings
$44.01 /

-0.605 (-1.36%)

10/30/20 Roth Capital
Roth upgrades Acushnet to Buy on 'universally positive' golf metrics
10/30/20 Roth Capital
Acushnet Holdings upgraded to Buy from Neutral at Roth Capital
06/29/20 SunTrust
Acushnet Holdings, Callaway Golf price targets raised at SunTrust
05/27/20 Roth Capital
Acushnet Holdings downgraded to Neutral at Roth Capital after strong run
GOLF Acushnet Holdings
$44.01 /

-0.605 (-1.36%)

Recommendations
Freshpet price target raised to $123 from $100 at Citi » 06:22
02/25/21
02/25
06:22
02/25/21
06:22
FRPT

Freshpet

$154.68 /

+8.82 (+6.05%)

Citi analyst Wendy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRPT Freshpet
$154.68 /

+8.82 (+6.05%)

FRPT Freshpet
$154.68 /

+8.82 (+6.05%)

02/24/21 DA Davidson
Freshpet price target raised to $194 from $172 at DA Davidson
02/24/21 Credit Suisse
Freshpet price target raised to $150 from $115 at Credit Suisse
02/23/21 JPMorgan
Freshpet price target raised to $187 from $170 at JPMorgan
01/21/21 Oppenheimer
Oppenheimer upgrades 'uniquely positioned' Freshpet to Outperform
FRPT Freshpet
$154.68 /

+8.82 (+6.05%)

  • 24
    Feb
  • 27
    Feb
FRPT Freshpet
$154.68 /

+8.82 (+6.05%)

Earnings
Bayer reports Q4 core EPS EUR1.32 vs. EUR1.44 last year » 06:22
02/25/21
02/25
06:22
02/25/21
06:22
BAYRY

Bayer

$0.00 /

+ (+0.00%)

Group sales amounted 10…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

02/10/21 Barclays
Bayer price target raised to EUR 55 from EUR 50 at Barclays
02/04/21
Citi opens positive 'Catalyst Watch' on Bayer
01/27/21 Deutsche Bank
Bayer price target raised to EUR 63 from EUR 62 at Deutsche Bank
01/20/21 Credit Suisse
Bayer price target raised to EUR 55 from EUR 47 at Credit Suisse
BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

Recommendations
Casper Sleep price target raised to $12 from $10 at Citi » 06:22
02/25/21
02/25
06:22
02/25/21
06:22
CSPR

Casper Sleep

$9.17 /

-0.26 (-2.76%)

Citi analyst Nicholas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSPR Casper Sleep
$9.17 /

-0.26 (-2.76%)

CSPR Casper Sleep
$9.17 /

-0.26 (-2.76%)

11/17/20
Fly Intel: Top five analyst downgrades
11/17/20 Morgan Stanley
Casper Sleep price target lowered to $6 from $8 at Morgan Stanley
11/17/20 Goldman Sachs
Casper Sleep downgraded to Neutral from Buy at Goldman Sachs
11/17/20 BofA
Casper Sleep downgraded to Underperform from Neutral at BofA
CSPR Casper Sleep
$9.17 /

-0.26 (-2.76%)

CSPR Casper Sleep
$9.17 /

-0.26 (-2.76%)

Upgrade
Avangrid upgraded to Buy from Neutral at Janney Montgomery Scott » 06:21
02/25/21
02/25
06:21
02/25/21
06:21
AGR

Avangrid

$45.59 /

+0.39 (+0.86%)

Janney Montgomery Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGR Avangrid
$45.59 /

+0.39 (+0.86%)

AGR Avangrid
$45.59 /

+0.39 (+0.86%)

10/26/20 UBS
PNM Resources downgraded to Neutral from Buy at UBS
10/22/20 Mizuho
PNM Resources downgraded to Neutral from Buy at Mizuho
10/21/20 Wells Fargo
PNM Resources downgraded to Equal Weight after Avangrid deal at Wells Fargo
10/15/20 Wells Fargo
Avangrid price target raised to $64 from $58 at Wells Fargo
AGR Avangrid
$45.59 /

+0.39 (+0.86%)

AGR Avangrid
$45.59 /

+0.39 (+0.86%)

Recommendations
Disney price target raised to $230 from $205 at Citi » 06:21
02/25/21
02/25
06:21
02/25/21
06:21
DIS

Disney

$197.52 /

+0.39 (+0.20%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DIS Disney
$197.52 /

+0.39 (+0.20%)

DIS Disney
$197.52 /

+0.39 (+0.20%)

02/23/21 Credit Suisse
SeaWorld price target raised to $52 from $34 at Credit Suisse
02/17/21 Argus
Disney price target raised to $225 from $200 at Argus
02/17/21 Morgan Stanley
Roku price target raised to $275 from $200 at Morgan Stanley
02/17/21 UBS
Disney price target raised to $215 from $200 at UBS
DIS Disney
$197.52 /

+0.39 (+0.20%)

DIS Disney
$197.52 /

+0.39 (+0.20%)

DIS Disney
$197.52 /

+0.39 (+0.20%)

DIS Disney
$197.52 /

+0.39 (+0.20%)

Downgrade
Wex downgraded to Peer Perform from Outperform at Wolfe Research » 06:20
02/25/21
02/25
06:20
02/25/21
06:20
WEX

Wex

$230.23 /

+0.71 (+0.31%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WEX Wex
$230.23 /

+0.71 (+0.31%)

WEX Wex
$230.23 /

+0.71 (+0.31%)

02/11/21 Susquehanna
Wex price target raised to $250 from $210 at Susquehanna
01/29/21 Barclays
Wex price target raised to $246 from $165 at Barclays
01/25/21 Deutsche Bank
Wex price target raised to $240 from $172 at Deutsche Bank
01/06/21 Wolfe Research
Wex upgraded to Outperform from Peer Perform at Wolfe Research
WEX Wex
$230.23 /

+0.71 (+0.31%)

Periodicals
GameStop's Jim Bell forced to resign by the board, Business Insider reports » 06:20
02/25/21
02/25
06:20
02/25/21
06:20
GME

GameStop

$91.70 /

+46.67 (+103.64%)

GameStop's CFO Jim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GME GameStop
$91.70 /

+46.67 (+103.64%)

GME GameStop
$91.70 /

+46.67 (+103.64%)

02/11/21 GLJ Research
GLJ calls end to Reddit-driven Tilray rally, predicts 100% share downside
02/01/21 Mizuho
Square benefited most from traders leaving Robinhood, says Mizuho
01/27/21 BofA
With GameStop shares trading at $213.50, BofA raises price target to $10
01/25/21 KeyBanc
Bed Bath & Beyond activity being driven by Reddit message board, says KeyBanc
GME GameStop
$91.70 /

+46.67 (+103.64%)

GME GameStop
$91.70 /

+46.67 (+103.64%)

GME GameStop
$91.70 /

+46.67 (+103.64%)

GME GameStop
$91.70 /

+46.67 (+103.64%)

Recommendations
PPD price target raised to $42 from $40 at Citi » 06:19
02/25/21
02/25
06:19
02/25/21
06:19
PPD

PPD

$35.33 /

-1.035 (-2.85%)

Citi analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PPD PPD
$35.33 /

-1.035 (-2.85%)

PPD PPD
$35.33 /

-1.035 (-2.85%)

10/29/20 Deutsche Bank
PPD price target raised to $38 from $33 at Deutsche Bank
10/12/20 Truist
PPD, Inc. initiated with a Buy at Truist
09/22/20 Mizuho
PPD, Inc. price target raised to $38 from $35 at Mizuho
09/21/20 Baird
PPD, Inc. price target raised to $40 from $36 at Baird
PPD PPD
$35.33 /

-1.035 (-2.85%)

  • 17
    Sep
PPD PPD
$35.33 /

-1.035 (-2.85%)

Upgrade
TrueCar upgraded to Buy from Hold at Benchmark » 06:19
02/25/21
02/25
06:19
02/25/21
06:19
TRUE

TrueCar

$5.07 /

+0.07 (+1.40%)

Benchmark analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRUE TrueCar
$5.07 /

+0.07 (+1.40%)

TRUE TrueCar
$5.07 /

+0.07 (+1.40%)

01/25/21 Goldman Sachs
TrueCar reinstated with a Neutral at Goldman Sachs
11/20/20 Needham
Ford launch an 'interesting response' to auto retailing shift, says Needham
11/11/20 Truist
TrueCar price target lowered to $4.50 from $6 at Truist
11/09/20
Fly Intel: Top five analyst upgrades
TRUE TrueCar
$5.07 /

+0.07 (+1.40%)

TRUE TrueCar
$5.07 /

+0.07 (+1.40%)

TRUE TrueCar
$5.07 /

+0.07 (+1.40%)

Downgrade
AT&T downgraded to Perform from Outperform at Oppenheimer » 06:18
02/25/21
02/25
06:18
02/25/21
06:18
T

AT&T

$29.38 /

+0.21 (+0.72%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
T AT&T
$29.38 /

+0.21 (+0.72%)

T AT&T
$29.38 /

+0.21 (+0.72%)

02/08/21 Deutsche Bank
AT&T price target lowered to $31 from $36 at Deutsche Bank
01/27/21 MoffettNathanson
AT&T leverage 'too high for a shrinking company,' says MoffettNathanson
01/04/21
Fly Intel: Top five analyst upgrades
01/04/21 Raymond James
AT&T upgraded to Outperform from Market Perform at Raymond James
T AT&T
$29.38 /

+0.21 (+0.72%)

T AT&T
$29.38 /

+0.21 (+0.72%)

T AT&T
$29.38 /

+0.21 (+0.72%)

T AT&T
$29.38 /

+0.21 (+0.72%)

Recommendations
Flowserve price target raised to $44 from $42 at Citi » 06:18
02/25/21
02/25
06:18
02/25/21
06:18
FLS

Flowserve

$38.67 /

-0.82 (-2.08%)

Citi analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FLS Flowserve
$38.67 /

-0.82 (-2.08%)

FLS Flowserve
$38.67 /

-0.82 (-2.08%)

01/04/21 Credit Suisse
Flowserve downgraded to Neutral from Outperform at Credit Suisse
12/15/20
Fly Intel: Top five analyst upgrades
12/15/20 Stifel
Flowserve upgraded to Buy at Stifel ahead of expected multiple expansion
12/15/20 Stifel
Flowserve upgraded to Buy from Hold at Stifel
FLS Flowserve
$38.67 /

-0.82 (-2.08%)

FLS Flowserve
$38.67 /

-0.82 (-2.08%)

FLS Flowserve
$38.67 /

-0.82 (-2.08%)

Upgrade
ODP Corporation upgraded to Neutral from Sell at UBS » 06:18
02/25/21
02/25
06:18
02/25/21
06:18
ODP

ODP Corporation

$41.40 /

-4.24 (-9.29%)

UBS analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ODP ODP Corporation
$41.40 /

-4.24 (-9.29%)

ODP ODP Corporation
$41.40 /

-4.24 (-9.29%)

01/12/21 JPMorgan
ODP Corporation upgraded to Neutral following Staples bid at JPMorgan
01/12/21 JPMorgan
ODP Corporation upgraded to Neutral from Underweight at JPMorgan
04/30/20 Sidoti
Office Depot initiated with a Buy at Sidoti
ODP ODP Corporation
$41.40 /

-4.24 (-9.29%)

ODP ODP Corporation
$41.40 /

-4.24 (-9.29%)

ODP ODP Corporation
$41.40 /

-4.24 (-9.29%)

Downgrade
Verizon downgraded to Perform from Outperform at Oppenheimer » 06:17
02/25/21
02/25
06:17
02/25/21
06:17
VZ

Verizon

/

+

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VZ Verizon
/

+

VZ Verizon
/

+

01/27/21 KeyBanc
Dycom upgraded to Overweight at KeyBanc
01/26/21 MoffettNathanson
Verizon path to outperformance 'narrower' due to auction, says MoffettNathanson
01/26/21 JMP Securities
Synchrony price target raised to $43 from $36 at JMP Securities
12/02/20
Fly Intel: Top five analyst upgrades
VZ Verizon
/

+

VZ Verizon
/

+

VZ Verizon
/

+

VZ Verizon
/

+

Upgrade
Square upgraded to Buy from Neutral at Guggenheim » 06:17
02/25/21
02/25
06:17
02/25/21
06:17
SQ

Square

/

+

Guggenheim analyst Jeff…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SQ Square
/

+

SQ Square
/

+

06:04 Today Guggenheim
Square upgraded to Buy from Neutral at Guggenheim
02/24/21
Fly Intel: Top five analyst downgrades
02/24/21 Credit Suisse
Square price target raised to $270 from $210 at Credit Suisse
02/24/21 Canaccord
Square price target raised to $280 from $200 at Canaccord
SQ Square
/

+

SQ Square
/

+

SQ Square
/

+

SQ Square
/

+

Recommendations
Sage Therapeutics price target raised to $86 from $74 at H.C. Wainwright » 06:17
02/25/21
02/25
06:17
02/25/21
06:17
SAGE

Sage Therapeutics

$84.59 /

+4.22 (+5.25%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAGE Sage Therapeutics
$84.59 /

+4.22 (+5.25%)

SAGE Sage Therapeutics
$84.59 /

+4.22 (+5.25%)

02/24/21 Stifel
Stifel cuts Sage target to $121, reiterates Buy after quarterly results
02/24/21 Wedbush
Sage has busy year ahead with Waterfall enrollment complete, says Wedbush
02/01/21 Raymond James
Sage Therapeutics resumed with a Market Perform at Raymond James
01/22/21
Sage Therapeutics cut to Market Perform at BMO Capital on valuation
SAGE Sage Therapeutics
$84.59 /

+4.22 (+5.25%)

SAGE Sage Therapeutics
$84.59 /

+4.22 (+5.25%)

Earnings
City Office REIT sees 2021 core FFO $1.20-$1,24, consensus $1.32  06:17
02/25/21
02/25
06:17
02/25/21
06:17
CIO

City Office REIT

$11.07 /

+0.3 (+2.79%)

 
ShowHide Related Items >><<
CIO City Office REIT
$11.07 /

+0.3 (+2.79%)

CIO City Office REIT
$11.07 /

+0.3 (+2.79%)

06/10/20 B. Riley FBR
City Office REIT price target raised to $13 from $12 at B. Riley FBR
03/27/20 Raymond James
City Office REIT downgraded after dividend cut at Raymond James
03/27/20 Raymond James
City Office REIT downgraded to Market Perform from Outperform at Raymond James
03/26/20 Compass Point
City Office REIT downgraded to Neutral from Buy at Compass Point
CIO City Office REIT
$11.07 /

+0.3 (+2.79%)

Recommendations
Coherus Biosciences price target lowered to $29 from $33 at H.C. Wainwright » 06:16
02/25/21
02/25
06:16
02/25/21
06:16
CHRS

Coherus Biosciences

$16.30 /

+0.1 (+0.62%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHRS Coherus Biosciences
$16.30 /

+0.1 (+0.62%)

CHRS Coherus Biosciences
$16.30 /

+0.1 (+0.62%)

11/19/20 Mizuho
Coherus Biosciences price target lowered to $30 from $35 at Mizuho
08/21/20 Mizuho
Express Scripts exclusion does not impact Coherus, says Mizuho
08/07/20 H.C. Wainwright
Coherus Biosciences price target raised to $33 from $30 at H.C. Wainwright
07/16/20
Fly Intel: Top five analyst initiations
CHRS Coherus Biosciences
$16.30 /

+0.1 (+0.62%)

Earnings
City Office REIT reports Q4 core FFO 32c , consensus 32c » 06:16
02/25/21
02/25
06:16
02/25/21
06:16
CIO

City Office REIT

$11.07 /

+0.3 (+2.79%)

Reports Q revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CIO City Office REIT
$11.07 /

+0.3 (+2.79%)

CIO City Office REIT
$11.07 /

+0.3 (+2.79%)

06/10/20 B. Riley FBR
City Office REIT price target raised to $13 from $12 at B. Riley FBR
03/27/20 Raymond James
City Office REIT downgraded after dividend cut at Raymond James
03/27/20 Raymond James
City Office REIT downgraded to Market Perform from Outperform at Raymond James
03/26/20 Compass Point
City Office REIT downgraded to Neutral from Buy at Compass Point
CIO City Office REIT
$11.07 /

+0.3 (+2.79%)

Syndicate
Avita Medical 2.795M share Spot Secondary priced at $21.50 » 06:15
02/25/21
02/25
06:15
02/25/21
06:15
RCEL

Avita Medical

$25.07 /

+0.96 (+3.98%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RCEL Avita Medical
$25.07 /

+0.96 (+3.98%)

RCEL Avita Medical
$25.07 /

+0.96 (+3.98%)

08/27/20
Fly Intel: Top five analyst initiations
08/27/20 BofA
Avita Medical assumed with a Buy at BofA
07/09/20 BTIG
Avita Medical price target raised to $41 from $8 at BTIG
07/06/20 Oppenheimer
Avita Medical price target raised to $45 from $9 at Oppenheimer
  • 25
    Feb
Recommendations
Teladoc price target lowered to $291 from $305 at Piper Sandler » 06:15
02/25/21
02/25
06:15
02/25/21
06:15
TDOC

Teladoc

$253.50 /

-2.26 (-0.88%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TDOC Teladoc
$253.50 /

-2.26 (-0.88%)

TDOC Teladoc
$253.50 /

-2.26 (-0.88%)

01/26/21 BTIG
Teladoc price target raised to $330 from $260 at BTIG
01/19/21 JPMorgan
Teladoc remains top 2021 healthcare technology pick at JPMorgan
01/15/21 Benchmark
SOC Telemed initiated with a Buy at Benchmark
01/12/21 BTIG
Teladoc price target raised to $260 from $240 at BTIG
TDOC Teladoc
$253.50 /

-2.26 (-0.88%)

TDOC Teladoc
$253.50 /

-2.26 (-0.88%)

TDOC Teladoc
$253.50 /

-2.26 (-0.88%)

TDOC Teladoc
$253.50 /

-2.26 (-0.88%)

Periodicals
Verizon tops 5G spectrum bidders with $45.5B pledge in FCC auction, WSJ reports » 06:14
02/25/21
02/25
06:14
02/25/21
06:14
VZ

Verizon

$57.11 /

+0.09 (+0.16%)

, T

AT&T

$29.38 /

+0.21 (+0.72%)

, TMUS

T-Mobile

$119.34 /

+0.3 (+0.25%)

Verizon (VZ) pledged…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VZ Verizon
$57.11 /

+0.09 (+0.16%)

T AT&T
$29.38 /

+0.21 (+0.72%)

TMUS T-Mobile
$119.34 /

+0.3 (+0.25%)

VZ Verizon
$57.11 /

+0.09 (+0.16%)

01/27/21 KeyBanc
Dycom upgraded to Overweight at KeyBanc
01/26/21 MoffettNathanson
Verizon path to outperformance 'narrower' due to auction, says MoffettNathanson
01/26/21 JMP Securities
Synchrony price target raised to $43 from $36 at JMP Securities
12/02/20
Fly Intel: Top five analyst upgrades
T AT&T
$29.38 /

+0.21 (+0.72%)

02/08/21 Deutsche Bank
AT&T price target lowered to $31 from $36 at Deutsche Bank
01/27/21 MoffettNathanson
AT&T leverage 'too high for a shrinking company,' says MoffettNathanson
01/04/21
Fly Intel: Top five analyst upgrades
01/04/21 Raymond James
AT&T upgraded to Outperform from Market Perform at Raymond James
TMUS T-Mobile
$119.34 /

+0.3 (+0.25%)

02/05/21 RBC Capital
T-Mobile price target raised to $133 from $120 at RBC Capital
02/05/21 Truist
T-Mobile price target raised to $150 from $135 at Truist
01/26/21 MoffettNathanson
Verizon path to outperformance 'narrower' due to auction, says MoffettNathanson
01/13/21 KeyBanc
T-Mobile price target raised to $155 from $135 at KeyBanc
VZ Verizon
$57.11 /

+0.09 (+0.16%)

T AT&T
$29.38 /

+0.21 (+0.72%)

TMUS T-Mobile
$119.34 /

+0.3 (+0.25%)

  • 24
    Jun
VZ Verizon
$57.11 /

+0.09 (+0.16%)

T AT&T
$29.38 /

+0.21 (+0.72%)

TMUS T-Mobile
$119.34 /

+0.3 (+0.25%)

VZ Verizon
$57.11 /

+0.09 (+0.16%)

T AT&T
$29.38 /

+0.21 (+0.72%)

TMUS T-Mobile
$119.34 /

+0.3 (+0.25%)

VZ Verizon
$57.11 /

+0.09 (+0.16%)

T AT&T
$29.38 /

+0.21 (+0.72%)

TMUS T-Mobile
$119.34 /

+0.3 (+0.25%)

Recommendations
Nvidia price target raised to $625 from $575 at Piper Sandler » 06:14
02/25/21
02/25
06:14
02/25/21
06:14
NVDA

Nvidia

$580.21 /

+14.61 (+2.58%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVDA Nvidia
$580.21 /

+14.61 (+2.58%)

NVDA Nvidia
$580.21 /

+14.61 (+2.58%)

02/22/21 BMO Capital
Nvidia price target raised to $680 from $650 at BMO Capital
02/22/21 Deutsche Bank
Nvidia price target raised to $550 from $515 at Deutsche Bank
02/18/21 Oppenheimer
Nvidia price target raised to $700 from $600 at Oppenheimer
02/18/21 Oppenheimer
Nvidia price target raised to $700 from $600 at Oppenheimer
NVDA Nvidia
$580.21 /

+14.61 (+2.58%)

NVDA Nvidia
$580.21 /

+14.61 (+2.58%)

NVDA Nvidia
$580.21 /

+14.61 (+2.58%)

NVDA Nvidia
$580.21 /

+14.61 (+2.58%)

Recommendations
UBS names Energy Transfer LP to Top Picks, raises price target raised to $16 » 06:14
02/25/21
02/25
06:14
02/25/21
06:14
ET

Energy Transfer LP

$8.13 /

+0.41 (+5.31%)

UBS analyst Shneur…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ET Energy Transfer LP
$8.13 /

+0.41 (+5.31%)

ET Energy Transfer LP
$8.13 /

+0.41 (+5.31%)

02/22/21 Piper Sandler
Energy Transfer LP upgraded to Overweight from Neutral at Piper Sandler
01/12/21 Barclays
Energy Transfer LP upgraded to Overweight from Equal Weight at Barclays
12/11/20 Morgan Stanley
Morgan Stanley upgrades midstream industry view to Attractive, shakes up ratings
12/11/20 Morgan Stanley
Energy Transfer LP upgraded to Overweight from Equal Weight at Morgan Stanley
ET Energy Transfer LP
$8.13 /

+0.41 (+5.31%)

ET Energy Transfer LP
$8.13 /

+0.41 (+5.31%)

ET Energy Transfer LP
$8.13 /

+0.41 (+5.31%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.